TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Urogyn Sverige AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/08 | 2021/08 |
Turnover |
5,204
|
4,170
|
3,361 |
Financial expenses |
63
|
19
|
0 |
Earnings before taxes |
-501
|
4,944
|
5,996 |
EBITDA |
-41,260
|
-19,917
|
-18,217 |
Total assets |
21,337
|
17,873
|
17,122 |
Current assets |
6,451
|
10,525
|
10,390 |
Current liabilities |
7,390
|
2,831
|
3,907 |
Equity capital |
9,198
|
13,639
|
11,735 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
23
|
14
|
13 |
Financial ratios
Fiscal year | 2023/12 | 2022/08 | 2021/08 |
Solvency |
43.1%
|
76.3%
|
68.5% |
Turnover per employee |
226
|
298
|
259 |
Profit as a percentage of turnover |
-9.6%
|
118.6%
|
178.4% |
Return on assets (ROA) |
-2.1%
|
27.8%
|
35.0% |
Current ratio |
87.3%
|
371.8%
|
265.9% |
Return on equity (ROE) |
-5.4%
|
36.2%
|
51.1% |
Change turnover |
1,034
|
809
|
197 |
Change turnover % |
25%
|
24%
|
6% |
Chg. No. of employees |
9
|
1
|
3 |
Chg. No. of employees % |
64%
|
8%
|
30% |
Total value of public sale
Fiscal year | 2023/12 | 2022/08 | 2021/08 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.